Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Accumulated Expenses (2022 - 2025)

Prokidney (PROK) has disclosed Accumulated Expenses for 4 consecutive years, with $28.7 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 7.73% to $28.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.7 million through Dec 2025, down 7.73% year-over-year, with the annual reading at $28.7 million for FY2025, 7.73% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $28.7 million at Prokidney, up from $26.1 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $31.1 million in Q4 2024, with the low at $5.3 million in Q1 2022.
  • Average Accumulated Expenses over 4 years is $17.2 million, with a median of $16.6 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses soared 175.48% in 2023, then fell 27.86% in 2024.
  • Over 4 years, Accumulated Expenses stood at $7.3 million in 2022, then soared by 140.8% to $17.7 million in 2023, then skyrocketed by 76.26% to $31.1 million in 2024, then fell by 7.73% to $28.7 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $28.7 million, $26.1 million, and $24.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.